Treatment of bladder carcinoma with 6 MeV linear accelerator.
D000328:Adult; D000368:Aged; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007422:Intestines / Q000528:radiation effects; D008297:Male; D008875:Middle Aged; D009372:Neoplasms, Connective Tissue / Q000401:mortality / Q000532:radiotherapy*; D009379:Neoplasms, Muscle Tissue / Q000401:mortality / Q000532:radiotherapy*; D011379:Prognosis; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy / Q000009:adverse effects; D001743:Urinary Bladder / Q000528:radiation effects; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000532:radiotherapy*